Kingsview Wealth Management LLC Increases Position in The Clorox Company (NYSE:CLX)

Kingsview Wealth Management LLC increased its stake in The Clorox Company (NYSE:CLXFree Report) by 3.2% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,643 shares of the company’s stock after purchasing an additional 177 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Clorox were worth $916,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. Brooklyn Investment Group increased its holdings in shares of Clorox by 163.8% in the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Prospera Private Wealth LLC purchased a new position in shares of Clorox in the 3rd quarter valued at about $27,000. Continuum Advisory LLC increased its holdings in shares of Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after purchasing an additional 138 shares in the last quarter. Carolina Wealth Advisors LLC purchased a new position in shares of Clorox in the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial purchased a new position in shares of Clorox in the 3rd quarter valued at about $49,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

CLX opened at $148.47 on Wednesday. The company’s 50 day simple moving average is $160.68 and its 200 day simple moving average is $159.16. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The stock has a market capitalization of $18.38 billion, a PE ratio of 40.56, a P/E/G ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the previous year, the firm earned $2.16 EPS. As a group, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 annualized dividend and a dividend yield of 3.29%. Clorox’s dividend payout ratio is presently 133.33%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on CLX. StockNews.com cut shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Evercore ISI increased their price objective on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Wells Fargo & Company increased their price objective on shares of Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 4th. Finally, DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. According to MarketBeat, Clorox currently has an average rating of “Hold” and a consensus target price of $158.21.

View Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.